6918 — A Plus Biotechnology Co Cashflow Statement
0.000.00%
- TWD2.54bn
- TWD2.03bn
- TWD835.89m
Annual cashflow statement for A Plus Biotechnology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 46.1 | 68.1 | 45.5 | 188 | 216 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 33.9 | 1.47 | 123 | 5.22 | -4.75 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -48.4 | -33.8 | -35.9 | -58.5 | -79.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 53 | 60.6 | 159 | 161 | 159 |
| Capital Expenditures | -225 | -36.8 | -9.8 | -9.13 | -13.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9.32 | 6.27 | 4.96 | -29.9 | -59.9 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -234 | -30.5 | -4.85 | -39 | -73.5 |
| Financing Cash Flow Items | -1.08 | 1.12 | 1.27 | 3.25 | -1.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 197 | -98.8 | -69.2 | -80.5 | 157 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.8 | -67.4 | 81.4 | 41.9 | 243 |